Advisory record · GHSA-7cm4-vmf2-8wf2

Dolibarr vulnerable to Eval Injection

CVSS 9.8 CriticalCriticalEPSS 0.35 · 98th percentile

Critical, because:

  • CVSS score 9.8: 9.0 or more.
  • CVSS score 9.8 (7.0 or more) and EPSS 0.35 (0.1 or more): a high score and a real chance of exploitation in the next 30 days.

How we decide what’s critical

Published by the GitHub Advisory Database at 12 Oct 2022, 19:00 UTC. agentprime has not analysed this yet, so whether it affects any app is not known.

PackageEcosystemAffectedFixed in
dolibarr/dolibarrPackagist<=15.0.3No fixed version yet
Identifiers
GHSA-7cm4-vmf2-8wf2 · BIT-dolibarr-2022-40871 · CVE-2022-40871 · PKSA-mbfz-b6r1-yyjp
Weakness (CWE)
CWE-94 · CWE-95
Published
12 Oct 2022
Updated
15 May 2025

Machine-written summary

Summary written by Claude Haiku from the source advisory. Not reviewed by a person.

Dolibarr ERP & CRM versions up to and including 15.0.3 are affected by eval injection. The description says that an administrator can be added through the installation page by default, and that malicious code can then be stored in the database and executed via eval. The source gives few details on how the attack is carried out. No fix is listed.

Written 3 Nov 2026.

Not analysed yet

We haven’t published our analysis of this Advisory yet. Once a person has reviewed it, this page will say what’s vulnerable, what has to be true for your app to be affected, and how to check.

Severity and exploitation

ScoreRatingCVSSVectorSource
9.8 Critical 3.1 CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H GitHub Advisory Database
  • CISA KEV Not listed.
  • EPSS 0.35, the 98th percentile, on 16 Nov 2026: FIRST’s estimate of the chance of exploitation in the next 30 days.

Timeline

  1. 31 Oct 2026, 14:27 UTC First seen by agentprime
  2. 31 Oct 2026, 14:27 UTC Confirmed by OSV

Sources

Facts on this page come from the GitHub Advisory Database (CC-BY 4.0), OSV and the other sources listed, as published. We don’t reproduce full advisory descriptions, which can contain exploit code.